RESMED INC·4

Nov 22, 8:11 PM ET

Leong Justin 4

4 · RESMED INC · Filed Nov 22, 2021

Insider Transaction Report

Form 4
Period: 2021-11-18
Leong Justin
Chief Product Officer
Transactions
  • Award

    ResMed Common Stock Options

    2021-11-18+8,1348,134 total
    Exercise: $263.16From: 2022-11-11Exp: 2028-11-18ResMed Common Stock (8,134 underlying)
Holdings
  • ResMed Common Stock

    49,730
Footnotes (1)
  • [F1]Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2022, 2023 and 2024.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT